In a research report issued today, MLV analyst Christopher Nolan maintained a Buy rating on Prospect Capital Corporation (NASDAQ:PSEC) with a price target of $10.50, which …
In a research report released Wednesday, MLV analyst Rich Eckert reiterated a Hold rating on ARMOUR Residential REIT (NYSE:ARR) and slightly raised the price …
MLV analyst Thomas Yip came out with a few insights on Geron Corporation (NASDAQ:GERN) after the company reported its first-quarter results and update on …
MLV analyst Thomas Yip came out with his views on OXiGENE Inc (NASDAQ:OXGN), after the company reported its first-quarter results and hosted a call to discuss the latest progress …
MLV’s healthcare analyst Vernon Bernardino came out with an optimistic view on Neostem Inc (NASDAQ:NBS), after the company announced the expansion of its existing contract manufacturing services agreement …
MLV analyst Vernon Bernardino came out today with a favorable report on Novavax, Inc. (NASDAQ:NVAX), as Fast Track designation was given by the FDA to MEDI-8897, a …
In a research report published Tuesday, MLV analyst Vernon Bernardino maintained a Buy rating on Pluristem Therapeutics Inc. (NASDAQ:PSTI) with a price target …
MLV analyst Vernon Bernardino weighed in today with a few insights on NeoStem Inc (NASDAQ:NBS), as the company is expected to announce randomization of the first …
In a research report released Wednesday, MLV analyst Raghuram Selvaraju reiterated a Buy rating on Cytosorbents Corp (NASDAQ:CTSO) with a $28 price target, which …
Lpath, Inc. (NASDAQ:LPTN) has been reiterated as a Buy at MLV by research analyst Arlinda Lee.
